Ardelyx (ARDX) Up on Xphozah’s Orphan Tag for Hyperphosphatemia
Ardelyx, Inc. ARDX announced that the FDA granted orphan drug designation to Xphozah (tenapanor) for the treatment of pediatric hyperphosphatemia. Xphozah is Ardelyx’s twice-daily oral tablet with a novel mechanism …